The drug pricing debate is top of mind with manufacturers, payers, governments, patients, and the medical professionals who treat them. In this issue of CRA Insights: Life Sciences we examine some of these issues.
CRA Insights: Blockchain & Crypto
Blockchain technologies are disrupting established industries as well as creating new ones. CRA’s experts bring the rigor of their expertise and credentials to...